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Family twin and adoption studies have noted the heritability of specific biological factors that influence suicidal behaviour. Exposure
to stress is one of the factors that strongly contribute to suicide attempts.The biological response to stress involves the hypothalamic-
pituitary-adrenal axis (HPA).Therefore, we found it interesting to study polymorphisms of genes involved in theHPA axis (CRHR1,
NR3C1, andAVPBR1).The study was performed on 597 patients, 225 of whom had a history of suicide attempts.We did not observe
any significant differences in the studied polymorphisms between the group of patients with a history of suicide attempts and
the control subjects. Our haplotype analysis of the AVPR1b gene revealed an association between the GCA haplotype and suicide
attempts; however, this association was not significant after correcting formultiple testing.We did not observe any other association
in haplotype andMDR analysis.We report here a comprehensive analysis of the HPA axis genes and a lack of association for genetic
variations regarding the risk of suicide attempts in affective disorder patients. Nonetheless, the inconsistencies with the previously
published results indicate the importance of the further investigation of these polymorphisms with respect to the risk of suicide
attempts.
1. Introduction
According to theWHO, approximately 1 million people com-
mit suicide each year. Therefore, suicide is considered a
major public health problem.The causes of suicidal behaviour
and suicide attempts are complex in that both genetic and
environmental factors can play a role. Exposure to an acute
or chronic stress accompanied by psychiatric conditions,
including substance abuse, depressedmood, anxiety, and also
psychotic features, can lead to suicide attempts.
Family twin and adoption studies have noted the heri-
tability of these features, suggesting that there is a specific
biological influence on suicidal behaviour. Genes containing
different variants, interindividual differences in psychology,
and related stress resilience may cause a vulnerability to
suicidal behaviour [1], as well as age, sex and the history of
the trauma. A majority of the genetic studies have involved
serotonin-related genes because levels of serotonin and its
metabolites are thought to play a role in suicidal behaviour.
Meta-analyses have confirmed an association between suici-
dal behaviour and 5HTT, (serotonin transporter), tryptophan
hydroxylase (TPH1), and brain-derived neurotropic factor
(BDNF) expression, as well as the expression of tyrosine
kinase receptor type 2 (NTRK2) [2, 3].
The biological response to stress involves the hypotha-
lamic-pituitary-adrenal axis (HPA), and prolonged stress
may change its function. These changes can be marked
by altered HPA activity (high or low cortisol levels) or
reactivity (reduced or increased feedback regulation). These
HPA disturbances are also thought to be partially predictive
of suicidal behaviour [4–6] and are regarded as an endophe-
notype of suicidal behaviour [5]. In particular, AVP receptor
upregulation may be critical for sustaining corticotropic
responsiveness during chronic stress or depression [7].
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Jokinen et al. suggested that dexamethasone suppression test
(DST) nonsuppression may be a biological suicide predictor
in depressed male suicide attempters [8, 9]. Those patients
may be genetically predisposed to react with high levels of
HPA activity in response to a low stress andmay experience a
chronic state of HPA activation [10, 11]. This reaction occurs
most likely via alteredCRHR1 (the gene controlling activation
of HPA axis) expression and functionality. Recently, Merali
and colleagues found that CRHR1 mRNA expression was
changed in the frontal cortices of suicide victims [12]. Hyper-
activity of the HPA axis predicts a worse treatment outcome
[13], and Binder et al. suggested that dysregulation of theHPA
axis may even predict a nonresponse to antidepressant treat-
ment particularly among males [14]. Both low CSF5-HIAA
and DST nonsuppression contribute to a fourfold increased
suicide risk in depressed subjects in a meta-analysis per-
formed byMann and Currier [5]. Some studies have reported
no association between the DST test and individual suscep-
tibility to suicide [15]. McGowan et al. observed epigenetic
modification of the glucocorticoid receptor gene as a function
of childhood abuse in the brains of suicide completers [16].
Thus, it is possible that HPA axis dysfunction is not linearly
related to suicide risk [17]. Therefore, it would be interesting
to study the polymorphisms of genes encoding receptors
and transporters involved in the regulation of HPA axis
function. Taking into account the limited number of genetic
studies that have been published previously on the associ-
ation between HPA axis genes and the history of suicide
attempts, we aimed in the present study to investigate the
possible association between NR3C1, CRHR1, and AVPR1b
gene polymorphisms and suicidal behaviour in unipolar (UP)
and bipolar (BP) patients.
2. Materials and Methods
2.1. Patients. We included 597 patients (367 female, 230
male), aged 18–84 (mean = 47, SD = 14) who met DSM-IV
criteria for bipolar disorder (391 BPI, 104 BPII) or recurrent
depression (𝑛 = 102) and were living in the Wielkopolska
region of Poland. The diagnosis was established using the
Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID-I) [18]. Among patients with BP disorder, 197 people
had a history of suicide attempt(s); among the UP patients,
28 people had a history of suicide attempt(s). The range of
duration for disease in our group was 1–54 years (mean 15
years, SD = 11). Informed consent was obtained from each
patient after the nature of the procedure had been fully
explained to them.
2.2. Control Group. The control group consisted of 712 sub-
jects. Control subjects were recruited from a group of healthy
volunteers, blood donors and hospital staff, and students of
the University of Medical Sciences in Poznan and the Clini-
cal Neuropsychology Unit, Collegium Medicum Bydgoszcz.
Only 40% of the control group were psychiatrically screened
using the Polish version of the M.I.N.I. Plus scale to exclude
individuals with any serious mental health problems. The
mean age was 37.7, SD = 12.5. The control group was matched
with age and sex. The study was approved by our local ethics
committee.
2.3. Genotyping. DNA was extracted from using the salting
out method [19]. SNP selection was carried out under the
following criteria: functionality (in experimental functional
studies), high frequency (MAF > 0.05), indication as a tag
SNP in HapMap, or previously reported associations with
psychiatric disorders (both positive and negative findings).
The SNPs chosen included both coding regions of known
functionality and noncoding regions (introns, UTRs) that
could affect gene regulation.TheNR3C1,CRHR1, andAVPR1b
polymorphisms were genotyped using TaqMan SNP Geno-
typing assays (Applied Biosystems) and TaqMan Genotyping
Master Mix. The list of SNPs analysed and the ID numbers
of the TaqMan assays were used according to previously
described findings [20]. For each reaction plate, nontemplate
controls (water) and genomic control DNA samples were
included. To check for genotyping accuracy control TaqMan
SNP genotyping assay was performed, 15% of randomly cho-
sen samples from both groups, and identical genotypes were
identified in all repeated samples. The clinical status of the
subjects was not known during genotyping. The genotyping
success rates were between 96.03% and 98.97%. The total
number of genotyped patients differs on the different SNPs
due to genotyping errors and therefore exclusions from
further studies.
2.4. Statistical Analysis. Two-tailed Pearson’s chi-squared
(𝜒2) test and Fisher’s exact test were, respectively, used to test
differences in the genotypic and allelic distribution between
the groups of patients and the control subjects. Two-tailed
power analysis was also performed. Calculations were per-
formed using Statistica version 9.0. Odds ratios were calcu-
lated using 2× 2 contingency tables by using Fisher’s exact test
in a demo version of GraphPad InStat 3 software. Linkage dis-
equilibrium (LD) between the CRHR1, AVPR1b, and NR3C1
polymorphisms was examined by pairwise comparisons of 𝑟2
and 𝐷󸀠 using Haploview version 4.1 [21]. Corrections for
multiple testing were performed for multiple comparisons
in the haplotype analysis and were completed for 10,000
permutations.
Higher-order gene-gene interactions among the tested
SNPs were analysed using the nonparametric and genetic
model-free multifactor dimensionality reduction (MDR)
approach (v.2.0 beta 8.3). All interactions were tested using
10-fold cross-validation in an exhaustive search considering
all possible SNP combinations. The model with the highest
testing balance accuracy and cross-validation consistency of
>5 out of 10 was selected as the “best model.” Statistical sig-
nificance was determined using a 1000-fold permutation test
(MDRpermutation testingmodule, v.1.0 beta 2).The software
is available online (http://www.epistasis.org/).
The power to detect an association for an odds ratio of 1.5
for our sample was about 80% for each SNP.
3. Results
3.1. HWE Analysis. The genotype distributions were in
Hardy-Weinberg equilibrium, except the following polymor-
phisms: rs16940655 of CRHR1, rs10052957, and rs258813 of
NR3C1, and rs28632197 ofAVPBR1 in the group of the patients
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Figure 1: Relative positions and LD estimates between NR3C1
polymorphisms in the analyzed population. Coloured squares cor-
respond to 𝐷󸀠 values with numerical estimates given within the
squares.
and the control group. We did not include those polymor-
phisms into the further analysis.
3.2. Association Analysis. We did not observe any significant
differences in the studied polymorphisms between the group
of patients with a history of suicide attempts and the control
subjects or in genotype distribution (results shown in Tables
1, 2, and 3, 0 = controls, 1 = suicidal patients) or allele
frequencies (data not shown). Analysis stratified by gender
also did not reveal any statistically significant differences
between patients with suicide attempts and the control group
(data not shown).We also compared the bipolar patients with
the history of suicide attempts versus bipolar patients without
suicide attempts in the past, but no significance was found
between the two groups (data not shown).
3.3. Haplotype Analysis. Linkage disequilibrium analysis of
the three analysed genes revealed strong linkage between the
polymorphisms. For theNR3C1 gene, we observed linkage for
5 out of 8 studied polymorphisms grouped in one haplotype
block (𝐷󸀠 = 1.0, LOD = 39.11, 𝑟2 = 0.162) (Figure 1).
However, none of the haplotypes were significantly more
frequent in the group of patients with suicide attempts
compared to the control group (Table 4).
For the CRHR1 gene, we observed linkage in 6 out of 7
polymorphisms grouped in two haplotype blocks: rs4076452,
rs4792887, are rs110402 in one block (𝐷󸀠 = 1.0, LOD = 37.66,
𝑟
2 = 0.216) and rs173365, rs242950, and rs878886 in the other
block (𝐷󸀠 = 1.0, LOD = 54.9, 𝑟2 = 0.285) (Figure 2).
Our haplotype analysis did not reveal any significant
differences in the haplotype frequencies of the two blocks
between patients with suicide attempts and control subjects
(Table 5).
For theAVPR1b gene, we observed linkage disequilibrium
for 3 out of 4 analysed polymorphisms grouped in one hap-
lotype block (𝐷󸀠 = 0.98, LOD = 45.56, 𝑟2 = 0.302) (Figure 3).
In our haplotype analysis, we observed an association
between the GCA haplotype and suicide attempts; however,
Table 1: Polymorphisms in GR (NR3C1) gene (genotypes).
rs41423247 CC CG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 65 13.03 239 47.9 195 39.8 0.55
1 27 13.5 87 43.5 86 43
rs6195 CC CT TT 𝑃
𝑛 % 𝑛 % 𝑛 %
0 450 88.93 56 11.07 0 0 0.28
1 177 88.5 22 11.0 1 0.5
rs6198 CC CT TT 𝑃
𝑛 % 𝑛 % 𝑛 %
0 14 2.8 116 23.2 370 74 0.33
1 3 1.53 54 27.55 139 70.92
rs6191 AA AC CC 𝑃
𝑛 % 𝑛 % 𝑛 %
0 136 27.15 244 48.7 121 24.15 0.72
1 57 29.38 88 45.36 49 25.26
rs6196 AA AG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 366 72.05 129 25.39 13 2.56 0.2
1 146 73 53 26.5 1 0.5
rs33388 AA AT TT 𝑃
𝑛 % 𝑛 % 𝑛 %
0 138 27.27 245 48.42 123 24.31 0.84
1 58 29.15 92 46.23 49 24.62
0: control. 1: suicidal patients.
Table 2: Polymorphisms in AVPR1b gene (genotypes).
rs28536160 CC CT TT 𝑃
𝑛 % 𝑛 % 𝑛 %
0 2 0.4 73 14.48 429 85.12
1 0 0 22 11 178 89 0.31
rs28373064 AA AG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 349 68.84 139 27.42 19 3.75
1 133 66.5 60 30 7 3.5 0.78
rs35369693 CC CG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 1 0.2 51 10.39 439 89.41 0.09
1 0 0 31 16.15 161 83.85
0: control. 1: suicidal patients.
this association was not significant after correction for mul-
tiple testing (𝑃 value of 0.130 after 10,000 permutations)
(Table 6).
3.4. Gene × Gene Interaction Analysis. The results of our
exhaustive MDR analysis evaluating combinations of all
tested SNPs are summarised in Table 7.
The best combination of possibly interactive polymor-
phisms in predicting suicidal attempts was observed in the
4-locus model. However, no significance was observed for
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Table 3: Polymorphisms of CRHR1 gene (genotypes).
rs4076452 CC CG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 11 2.54 142 32.79 280 64.67 0.48
1 5 3.09 45 27.78 112 69.14
rs12936511 CC CT TT 𝑃
𝑛 % 𝑛 % 𝑛 %
0 394 91.8 34 7.93 1 0.23
1 149 91.98 12 7.41 1 0.62 0.75
rs4792887 CC CT TT 𝑃
𝑛 % 𝑛 % 𝑛 %
0 332 77.2 94 21.86 4 0.93
1 130 79.75 32 19.63 1 0.61 0.77
rs242950 CC CT TT 𝑃
𝑛 % 𝑛 % 𝑛 %
0 325 75.4 99 22.97 7 1.62 0.81
1 126 77.78 34 20.99 2 1.23
rs878886 CC CG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 304 70.2 118 27.25 11 2.5 0.5
1 106 65.4 51 31.48 5 3.09
rs173365 AA AG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 78 18.01 206 47.58 149 34.41 0.9
1 28 17.18 77 47.24 58 35.58
rs110402 AA AG GG 𝑃
𝑛 % 𝑛 % 𝑛 %
0 98 22.9 216 50.47 114 26.64
1 39 24.07 87 53.7 36 22.22 0.5
0: control. 1: suicidal patients.
Table 4: Comparison of haplotype frequencies for the analysed








TCAGT 0.478 0.475 : 0.479 0.015 0.901
TAAGA 0.222 0.218 : 0.224 0.072 0.788
CAAAA 0.150 0.170 : 0.142 1.711 0.190
TAGAA 0.144 0.135 : 0.147 0.332 0.564
this combination (the testing balanced accuracy for this 4-
locus model was 90%, cross-validation consistency was 5/10
(50%), and an empiric 𝑃 value of 0.589 is based on 1000-fold
permutations). Similarly, other combinations of the analysed
polymorphisms also did not reach statistical significance
in predicting susceptibility to an increased risk of suicide
attempts.
Table 5: Comparison of haplotype frequencies for the analysed








GCA 0.489 0.510 : 0.481 0.755 0.385
GCG 0.323 0.321 : 0.323 0.0050 0.943
CTG 0.110 0.104 : 0.112 0.166 0.683
CCG 0.074 0.065 : 0.077 0.487 0.485
Block 2
GCC 0.584 0.592 : 0.581 0.118 0.731
ACG 0.169 0.187 : 0.162 1.061 0.303
ATC 0.127 0.118 : 0.130 0.312 0.576
ACC 0.120 0.103 : 0.127 1.29 0.256
Table 6: Comparison of haplotype frequencies for the analysed








AGG 0.823 0.814 : 0.826 0.291 0.589
GGG 0.076 0.068 : 0.079 0.547 0.459
GCA 0.060 0.081 : 0.052 4.087 0.043∗
GGA 0.041 0.037 : 0.042 0.162 0.687
∗Not significant after correction for multiple test using 10.000 permutations
(𝑃 = 0.130).
4. Discussion
The results of our study suggested a possible association
between the haplotype of the AVPR1b gene and suicide
attempts, which did not reach significance after multiple test-
ing correction.We did not find any interactions for genotypes
or for the alleles of the studied polymorphisms in the group of
suicidal patients. Also Dempster et al. suggested the involve-
ment of the AVPR1b gene polymorphisms in the etiology of
childhood onset mood disorders particularly in females [22].
Ben-Efraim et al. found association between the high Beck
scale results in patients with suicide attempts and rs33990840
and a major 6-SNP haplotype of AVPR1b gene [23]. Previ-
ously, we reported the association between the rs28536160
polymorphism of the AVPR1b gene and rs1293651 of the
CRHR1 gene and bipolar patients with psychotic features
[20]. In this study, we did not find association between poly-
morphisms of CRHR1 gene and suicidal patients although
Wasserman et al. identified a CRHR1 SNP that showed an
association in the suicide attempters exposed to low-medium
stress and a relationship between neurotic personality traits
and suicidality. The genetic variation in the TBX19 gene (a
regulator of the HPA axis) was observed by Wasserman et al.
[24, 25]. In suicidal males, they found an association between
the T and A alleles of SNPs rs4792287 and rs110402 and the
T allele of rs12936511 of the CRHR1 gene. Polymorphisms in
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Table 7: Multilocus interaction model for the risk of suicide attempts with the NR3C1. AVPR1b and CRHR1 genes by the MDR method.
Model Loci combination Testing balancedaccuracy (%)
Cross-validation
consistency (%) 𝑃 value
2-locus Rs258813 of NR3C1 and rs110402 of CRHR1 47 30 0.989
3-locus Rs41423247 and rs258813 of NR3C1 and rs110402of CRHR1 52 50 0.760
4-locus Rs41423247 and rs258813 of NR3C1. rs28373064 ofAVPR1b and rs110402 of CRHR1 50 90 0.589
1 2 3 4 6 7 8







































Figure 2: Relative positions and LD estimates between AVPR1b
polymorphisms in the analyzed population. Coloured squares cor-
respond to 𝐷󸀠 values with numerical estimates given within the
squares.
the CRHR1 gene have also been associated with depression
and the treatment efficiency of depression [26–29]. Papiol et
al. showed associations of the A allele of the CRHR1 rs110402
SNP with hte age of onset and with seasonal pattern of major
depression [29]. Bradley et al. reported that theT andGalleles
of the rs4792887 and rs110402 CRHR1 SNPs were linked with
depression [26]. In the study performed by De Luca et al. an
association between haplotype variation at the CRHR2 locus
and suicidal behaviour was observed [30]. Interestingly, they
also found interactions between polymorphisms of CRHR1
gene in suicidal schizophrenic patients [31]. We did not find
an association between the polymorphisms of the NR3C1,
CRHR1, and AVPBR1 genes and the whole group of affective
disorder patients (data not published). However, in the study
performed by Szczepankiewicz et al. [32], an association
between NR3C1 polymorphisms and depression was found.
Themain limitations of our study that might have yielded
false-positive or- negative results include the following: the
limited sample size of the patient group (𝑛 = 225), the fact
that only 40% of the control group had been screened for
psychiatric disorders, and the lack of Hardy-Weinberg equi-
librium for the four analysed SNPs.However, taking into con-
sideration the lifetime prevalence of psychiatric disorders and
the power of the studied polymorphisms (>80%), it seems



























Figure 3: Relative positions and LD estimates between CRHR1
polymorphisms in the analyzed population. Coloured squares cor-
respond to 𝐷󸀠 values with numerical estimates given within the
squares.
5. Conclusions
We report here a comprehensive analysis of HPA axis genes
and a lack of association of genetic variation with the risk of
suicide attempts in affective disorder patients. Nonetheless,
the inconsistencieswith the previously published associations
indicate the importance of further investigation of those
polymorphisms with respect to the risk of suicide attempts.
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[29] S. Papiol, B. Arias, C. Gastó, B. Gutiérrez, R. Catalán, and L.
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